• Factor B Complement Antigen
  • Chlamydia trachomatis NAAT, Liquid Cytology
  • G-protein gated Inwardly Rectifying K+ channel 1 (GIRK1) Genotyping
  • Cortisol/Cortisone, Free, 24 Hour, Urine
  • Bilirubin, Direct, Serum
  • Biopsy, Frozen Section
  • Mu-opioid receptor 1 (OPRM1) Genotyping
  • Tuberculosis Cell Mediated Immunity Antigen Response (QuantiFERON®-TB Gold ) Test
  • HER2/neu (ERBB2), IHC, Semi Quantitative, Automated
  • CxBladder™ (Detect, Triage, Triage Enhanced, Monitor) Bladder Cancer Test
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Mutation Analysis
Medical Test

Interpretation
Access to Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Mutation Analysis is restricted.
Loading...